S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market

First Wave BioPharma (FWBI) News Today

$2.60
-0.24 (-8.45%)
(As of 04/19/2024 ET)
SourceHeadline
finance.yahoo.com logoFirst Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
finance.yahoo.com - April 17 at 12:00 PM
globenewswire.com logoFirst Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference
globenewswire.com - April 15 at 7:00 AM
investing.com logoFirst wave BioPharma CEO sells shares to cover tax obligations
investing.com - April 5 at 9:01 AM
investing.com logoFirst wave BioPharma CFO sells shares worth over $5,500
investing.com - March 21 at 6:57 PM
investing.com logoFirst wave BioPharma CEO sells shares worth over $9,000
investing.com - March 21 at 6:57 PM
globenewswire.com logoFirst Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
globenewswire.com - March 18 at 7:00 AM
investorplace.com logoWhy Is First Wave BioPharma (FWBI) Stock Up Today?
investorplace.com - March 14 at 8:05 AM
msn.com logoFirst Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease
msn.com - March 14 at 7:44 AM
globenewswire.com logoFirst Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
globenewswire.com - March 14 at 6:00 AM
finance.yahoo.com logoFirst Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
finance.yahoo.com - March 5 at 7:40 AM
globenewswire.com logoFirst Wave BioPharma to Participate In ‘Fireside Chat' at the 36th Annual Roth Conference
globenewswire.com - March 5 at 7:00 AM
marketwatch.com logoFirst Wave BioPharma Shares Drop 25% After Direct Offering Prices
marketwatch.com - March 4 at 10:54 AM
msn.com logoFirst Wave Biopharma to raise about $4M of proceeds in direct offering
msn.com - March 4 at 10:54 AM
finance.yahoo.com logoFirst Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
finance.yahoo.com - March 4 at 10:54 AM
finance.yahoo.com logoFirst Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
finance.yahoo.com - February 13 at 9:47 AM
finance.yahoo.com logoFirst Wave BioPharma to Present at the DealFlow MicroCap Conference
finance.yahoo.com - January 23 at 9:40 AM
benzinga.com logoThis BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024
benzinga.com - January 22 at 2:56 PM
msn.com logoFirst Wave BioPharma files to sell 1.76M for holders
msn.com - January 8 at 6:47 PM
msn.com logoFirst Wave expecting "significant" investments if ImmunogenX deal closes
msn.com - January 6 at 9:46 AM
finance.yahoo.com logoFirst Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024
finance.yahoo.com - January 4 at 9:11 AM
msn.com logoWhat's Going On With First Wave BioPharma Stock?
msn.com - January 3 at 7:27 PM
marketbeat.com logo
marketbeat.com - January 3 at 9:36 AM
realmoney.thestreet.com logoFirst Wave BioPharma price target set at $40 at Roth MKM
realmoney.thestreet.com - January 3 at 9:27 AM
markets.businessinsider.com logoBuy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac Treatment
markets.businessinsider.com - January 3 at 9:27 AM
marketbeat.com logo
marketbeat.com - December 28 at 12:36 PM
marketbeat.com logo
marketbeat.com - December 28 at 12:27 PM
markets.businessinsider.com logoCrude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
markets.businessinsider.com - December 27 at 6:31 PM
msn.com logoWhy First Wave BioPharma Shares Are Skyrocketing Today
msn.com - December 27 at 1:30 PM
finance.yahoo.com logoFirst Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
finance.yahoo.com - December 27 at 1:30 PM
marketbeat.com logo
marketbeat.com - December 27 at 12:03 PM
marketbeat.com logo
marketbeat.com - December 27 at 11:57 AM
marketbeat.com logo
marketbeat.com - December 27 at 10:01 AM
marketbeat.com logo
marketbeat.com - December 27 at 9:52 AM
marketbeat.com logo
marketbeat.com - December 27 at 9:33 AM
markets.businessinsider.com logoFirst Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical Company
markets.businessinsider.com - December 27 at 8:30 AM
finance.yahoo.com logoFirst Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program
finance.yahoo.com - December 27 at 8:30 AM
marketbeat.com logo
marketbeat.com - December 20 at 2:18 PM
investorplace.com logoFWBI Stock Earnings: First Wave BioPharma Beats EPS for Q3 2023
investorplace.com - December 20 at 11:05 AM
investorplace.com logoFWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023
investorplace.com - December 20 at 11:05 AM
finance.yahoo.com logoUPDATED: First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipeline
finance.yahoo.com - December 18 at 6:46 PM
markets.businessinsider.com logoFirst Wave BioPharma To Acquire ImmunogenX In All-stock Transaction
markets.businessinsider.com - December 18 at 8:45 AM
msn.com logoFirst Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipeline
msn.com - December 18 at 8:45 AM
finance.yahoo.com logoFirst Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
finance.yahoo.com - December 18 at 8:45 AM
marketbeat.com logo
marketbeat.com - December 18 at 6:05 AM
msn.com logoFirst Wave BioPharma approves a 1-for-20 reverse stock split
msn.com - December 14 at 3:35 PM
finanznachrichten.de logoFirst Wave BioPharma, Inc.: First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders
finanznachrichten.de - December 14 at 10:35 AM
finance.yahoo.com logoFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders
finance.yahoo.com - December 14 at 10:35 AM
finance.yahoo.com logoFirst Wave BioPharma to Participate in BIO Partnering @JPM During “J.P. Morgan Week 2024”
finance.yahoo.com - December 6 at 8:38 AM
finance.yahoo.com logoFirst Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference
finance.yahoo.com - December 5 at 11:34 AM
nz.finance.yahoo.com logoFirst Wave BioPharma, Inc. (3660.F)
nz.finance.yahoo.com - November 29 at 12:26 AM
Get First Wave BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter.

Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

FWBI Media Mentions By Week

FWBI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FWBI
News Sentiment

0.00

0.50

Average
Medical
News Sentiment

FWBI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FWBI Articles
This Week

2

1

FWBI Articles
Average Week

Get First Wave BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FWBI) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners